Skip to main content

Table 1 Patients' profile at starting of treatment

From: Dotinurad restores exacerbated kidney dysfunction in hyperuricemic patients with chronic kidney disease

Characteristics

 Age, years

65.4 ± 14.8

 Male, n (%)

25 (71.4)

 Body mass index, kg/m2

23.4 ± 5.2

 Systolic blood pressure, mmHg

133 ± 18

 Diastolic blood pressure, mmHg

77 ± 15

 Primary CKD, n

  Chrinic glomerulonephritis

17

  Diabetic kidney disease

8

  Nephrosclerosis

5

  Gout kidney

5

Laboratory data

 Hemoglobin, g/dL

12.8 ± 2.4

 Serum albumin, g/dL

4.0 ± 0.5

 HbA1c, % (NGSP)

6.0 ± 0.8

 Serum creatinine, mg/dL

1.9 ± 0.87

 eGFR-cre, mL/min/1.73 m2

31.8 ± 16.4

  30 or higher (%)

17 (48.6%)

  < 30 (%)

18 (51.4%)

 Serum uric acid, mg/dL

8.1 ± 1.7

 C-reactive protein, mg/dL

0.50 ± 0.53

 Urinary protein, g/gCr

1.1 ± 1.2

 Fractional excretion of uric acid, %

7.56 ± 4.68